Consequently, our data demonstrate that ATG16L1-deficiency in myeloid cells promotes LP TRM cell accumulation and increases the susceptibility to colitis by impairing the activation of TLR7 signaling in response to RNA viruses. The gene discussed is TLR7; the disease is colitis.